BAX Nov 2024 42.500 call
| Previous close | 0.3500 |
| Open | 0.2900 |
| Bid | 0.2000 |
| Ask | 0.5500 |
| Strike | 42.50 |
| Expiry date | 2024-11-15 |
| Day's range | 0.2900 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 142 |
- Business Wire
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
DEERFIELD, Ill., June 06, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time.
Simply Wall St.Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
The board of Baxter International Inc. ( NYSE:BAX ) has announced that it will pay a dividend of $0.29 per share on the...
Business WireNew Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
DEERFIELD, Ill., May 29, 2024--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis (HF HD). The study, "Survival of expanded hemodialysis and high-flux hemodialysis patients in Colombia: a cohort study," was prese
